Business Wire

LG Chem LUCON® TX5007, the Engineering Plastic Used for Electrostatic Powder Coating Is Now Applied to Japanese Global OEM’s Front Fenders

Share

LG Chem (KRX: 051910) has started supplying engineering plastics to Mitsubishi Motors for its powder coating parts used as the front fenders of RVR, Delica D:5 and Outlander models.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230103005882/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

RVR (Photo: Business Wire)

Front fender is located on the side of the vehicles, which not only acts as one of key factors in the exterior design but also protects its wheels from road debris. Thus, it not only should possess a high level of mechanical robustness but also an excellent exterior quality to keep a high integrity design with the rest of the car body.

LUCON TX5007 developed by LG Chem is a compound material that combines modified polyphenylene ether (mPPE) and polyamide (PA66) alloy with carbon nanotubes (CNTs), and has an excellent electrical conductivity and show strong mechanical properties. In addition, this product has an outstanding heat resistance, making it suitable for the automotive on-the-line painting process at 200 °C or higher. At the same time, it also provides an excellent dimensional stability thanks to its low coefficient of linear thermal expansion (CLTE).

In general, applying plastics instead of steel/aluminum contributes to automotive light weight. When a plastic fender is used, the weight of the vehicle is reduced by about 4 kg, which also improves fuel efficiency. Furthermore, plastic fenders can provide other benefits, such as reduced fuel exhaust emissions and carbon footprints.

In addition to LUCON TX5007, LG Chem has a broad portfolio of products that can be used for large-scale automotive exterior parts that need to utilize powder coating process. These products can be customized to meet automotive suppliers’ diverse parts requirements for fenders, bumper panels, hoods, tailgates, fuel doors, and side mirrors.

At the same time, LG Chem is using CNT, a filler that produces excellent conductivity even with a small amount in its engineering plastics to support diverse requirements of customers. Since this material can cover a wider range of electrical conductivity compared to other carbon fillers such as Carbon Black and Carbon Fiber, it is considered an optimal solution for powder coating. LG Chem has not only built its own CNT production line, but now expanding its 4th plant for a mass production in 2024, for the reliable supply of high-quality products for powder coating.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

LG Chem, Ltd.
Sangkuhn Sung, Manager
+82-2-3773-5136
sungsk@lgchem.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Polpharma Biologics and Libbs Farmacêutica Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases10.12.2025 08:01:00 EET | Press release

Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, is thrilled to announce the signing of a landmark licensing agreement with the Brazilian company Libbs Farmacêutica! Through this strategic partnership, Libbs Farmacêutica will gain exclusive rights to commercialize a cutting-edge biosimilar for autoimmune diseases in the rapidly growing Brazilian market. Polpharma Biologics retains full responsibility for the development and manufacturing of the biosimilar. Libbs Farmacêutica will hold an exclusive license for the commercialization, marketing and distribution of the biosimilar in Brazil. This collaboration opens up exciting new opportunities and demonstrates the shared commitment of both companies to delivering innovative and accessible therapies to patients. “Entering the Brazilian market with a biosimilar is a significant step for Polpharma Biologics and reflects our ongoing mission to expand access to high-qual

NayaPay Launches Global QR Payments for Pakistanis via Alipay+10.12.2025 06:00:00 EET | Press release

NayaPay, one of Pakistan’s fastest growing fintech platforms, has launched global QR payments in collaboration with Alipay+, Ant International’s global wallet gateway. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251209591389/en/ The partnership enables millions of NayaPay users to scan-and-pay at Alipay+ merchants initially across more than 50 countries, connecting Pakistani consumers to an extensive global ecosystem spanning retail, dining, transport, healthcare, entertainment and more. With this innovative feature, paying abroad just got faster and more affordable. With NayaPay, Pakistanis can now scan and pay securely worldwide with lower costs, less friction, and a seamless checkout experience wherever they go. Alipay+ connects 40 international mobile payment partners to more than 150 million merchants globally. The launch reinforces NayaPay’s commitment to delivering world-class payment experiences to Pakistani consu

Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator10.12.2025 04:50:00 EET | Press release

Biocytogen (Beijing) Pharmaceutical Technology Co., Ltd. (“Biocytogen,” SSE: 688796; HKEX: 02315), a global biotechnology company advancing innovative drug discovery, today announced its successful listing on the Shanghai Stock Exchange STAR Market. This follows the Company’s listing on the Hong Kong Stock Exchange in September 2022 and marks a significant milestone in establishing Biocytogen as the first “H+A” dual-listed global drug innovator, reinforcing its mission to become the global headstream of new drugs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251209977992/en/ The Company’s IPO price was set at 26.68 RMB per share, with an opening price of 58 RMB, representing a 117% increase over the offering price. Based on the opening price, Biocytogen’s market capitalization exceeds 25.9 billion RMB. Biocytogen’s proprietary RenMice® platforms (RenMab™, RenLite®, RenNano®, RenTCR-mimic™) enable the discovery of fully hum

Argo Infrastructure Partners Increases Ownership and Capital Commitment to TierPoint10.12.2025 00:00:00 EET | Press release

Argo Infrastructure Partners, LP (“Argo”), an established mid-market asset manager of essential infrastructure assets in North America, today announced it has acquired on behalf of its managed funds the equity interests of the majority of minority shareholders in TierPoint. The transaction reflects Argo’s continued conviction in TierPoint’s strategy and growth potential during a period of accelerating demand for TierPoint’s enterprise-class data center services. Since Argo’s initial investment in 2020, $3 billion of capital has been raised to fund growth and reduce TierPoint’s cost of capital by terming out debt facilities. The investment capital has advanced TierPoint’s market position as a data center services provider to enterprises, government organizations, hyperscalers and other consumers of state-of-the-art digital infrastructure. With these investments, Argo has supported the national expansion of TierPoint’s data center platform, and its efforts to meet and exceed customers’ r

Venture Global Announces Closing of $3,000,000,000 Senior Secured Notes by Venture Global Plaquemines LNG, LLC9.12.2025 23:30:00 EET | Press release

Venture Global, Inc. (“Venture Global”, NYSE: VG) announced today that its subsidiary, Venture Global Plaquemines LNG, LLC (“VGPL”) has closed an offering of $3,000,000,000 aggregate principal amount of senior secured notes, which has been issued in two series: (i) a series of 6.125% senior secured notes due 2030 in an aggregate principal amount of $1,750,000,000 (the “2030 Notes”) and (ii) a series of 6.500% senior secured notes due 2034 in an aggregate principal amount of $1,250,000,000 (the “2034 Notes” and, together with the 2030 Notes, the “Notes”). The 2030 Notes will mature on December 15, 2030, and the 2034 Notes will mature on June 15, 2034. Venture Global had previously announced the issuance of $2,500,000,000 of senior secured notes by VGPL on April 21, 2025, and $4,000,000,000 of senior secured notes by VGPL on July 3, 2025 (collectively, the “Existing Notes”), bringing the combined aggregate amount of senior secured notes issued by VGPL to $9,500,000,000 since the project

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye